| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
350.0990 | 0 | 0 | 1,255.6810 | 1,202.1690 |
| Cost of Revenue
|
-1,037.2650 | -- | -1,065.5740 | -1,017.4930 | -929.4410 |
|
Gross Profit
|
358.8090 | -- | 267.8290 | 238.1880 | 272.7280 |
| Selling, General and Administrative Expenses
|
-7,024.8630 | -7,984.0360 | -3,994.6620 | -7,420.2240 | -6,984.2950 |
|
Research and Development Expenses
|
-- | -- | -- | -109.6180 | -731.3280 |
|
Operating Income/Expenses
|
-8,150.8630 | -7,984.0360 | -3,994.6620 | -7,420.2240 | -7,715.6230 |
|
Total Operating Profit/Loss
|
-8,319.6020 | -7,984.0360 | -3,994.6620 | -7,182.0360 | -7,442.8950 |
| Total Net Finance Income/Expense
|
-353.5450 | -1,456.6940 | -1,659.7450 | -1,351.5020 | -3,576.3330 |
| Net Investment Income
|
-1,183.8400 | 930.8900 | -472.2230 | -8,383.2730 | 558.8860 |
| Irregular Income/Expenses
|
1,650 | -9,076.5870 | -838.7940 | 228.3000 | -1,350 |
|
Other Income/Expense, Non-Operating
|
73.3310 | 67.5540 | -74.1800 | -18.4990 | -120.5050 |
|
Non-Operating Income/Expenses, Total
|
185.9460 | -9,534.8370 | -3,044.9420 | -9,524.9740 | -4,487.9520 |
|
Pretax Income
|
-8,133.6560 | -17,518.8730 | -7,039.6040 | -16,707.0100 | -11,930.8470 |
|
Provision for Income Tax
|
0 | 0 | 0 | 0 | 0 |
|
Net Income from Continuing Operations
|
-8,133.6560 | -17,518.8730 | -7,039.6040 | -16,707.0100 | -11,930.8470 |
|
Discontinued Operations
|
-845.1180 | -742.1030 | -863.7900 | -- | -- |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-8,978.7740 | -18,260.9760 | -7,903.3940 | -16,707.0100 | -11,930.8470 |
|
Non-Controlling/Minority Interests
|
0 | 0 | 0 | 0 | 0 |
|
Net Income after Non-Controlling/Minority Interests
|
-8,978.7740 | -18,260.9760 | -7,903.3940 | -16,707.0100 | -11,930.8470 |
|
Other Adjustments to Net Income Available to Common Stockholders
|
0 | 162.4730 | 0 | -- | -- |
|
Net Income Available to Common Stockholders
|
-8,978.7740 | -18,098.5030 | -7,903.3940 | -16,707.0100 | -11,930.8470 |
|
Diluted Net Income Available to Common Stockholders
|
-8,978.7740 | -18,098.5030 | -7,903.3940 | -16,707.0100 | -11,930.8470 |
| Basic EPS
|
-2.80 | -112.80 | -168.80 | -476.00 | -384.00 |
| Diluted EPS
|
-2.80 | -112.80 | -168.80 | -476.00 | -384.00 |
|
Basic Weighted Average Shares Outstanding
|
423.0920 | 160.5390 | 46.8310 | 35.0970 | 31.0950 |
|
Diluted Weighted Average Shares Outstanding
|
423.0920 | 160.5390 | 46.8310 | 35.0970 | 31.0950 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-7,780.1110 | -16,062.1790 | -5,379.8590 | -15,355.5080 | -8,354.5140 |
|
EBITDA
|
-6,493.6170 | -15,903.3480 | -5,256.6950 | -15,025.5620 | -7,888.2340 |
|
Normalized EBITDA
|
-5,201.6410 | -5,548.5120 | -4,159.7240 | -14,262.4750 | -6,010.0640 |
12/31/2022 - 3/27/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade